REGN241129C1020000
- 2.00
- 0.000.00%
Regeneron Pharmaceuticals Newsroom
Intellia Therapeutics' Nex-z Receives FDA Regenerative Medicine Advanced Therapy Designation
S&P 500, Dow Hit Records Right After Open | Live Stock
Citi Maintains Regeneron Pharmaceuticals(REGN.US) With Hold Rating, Maintains Target Price $895
Bernstein Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Maintains Target Price $1,110
Regeneron Pharmaceuticals (NASDAQ:REGN) Shareholders Have Earned a 15% CAGR Over the Last Five Years
Pfizer Meets Amyloidosis Rival as BridgeBio Wins FDA Nod for Attruby
Weekly Buzz: Nvidia Falls on Near Perfect Report, but Only For a Day
Catalyst Watch: Robotaxi IPO, OPEC+, Holiday Shopping Data, and Movie Blockbusters
Market Climbs, Bitcoin Close to $100k | Live Stock
Bitcoin Hits $99k, Thursday Market Whiplash Following Nvidia Price | Wall Street Today
Bitcoin Hits $98k, Nvidia Falls on Forward Guidance, Google Chrome Break-Up | Live Stock
Nvidia Forward Guidance Was Not Perfect, Market Flat | Wall Street Today
Market Falls on Retail Results, Bitcoin Swells, All Eyes on Nvidia | Live Stock
Bitcoin Climbs to Fresh High, Market Shifts into Climb | Wall Street Today
Regeneron Pharmaceuticals, Inc. (REGN) Jefferies London Healthcare Conference (Transcript)
High Alpha Stocks That Are Rated 'Overweight' – MS
Regeneron Pharmaceuticals's Options: A Look at What the Big Money Is Thinking
Tuesday Market Falls, SMCI Flies, Big Box Retail Reports Mixed | Live Stock
Here's Why Regeneron Pharmaceuticals (REGN) Declined in Q3
Monday Market Slow but Steady, Trump Buying Crypto Firm | Wall Street Today